Hedvat; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hedvat; Michael.The latest application filed is for "bispecific and monospecific antibodies using novel anti-pd-1 sequences".

Company Profile

13.6.19

Hedvat; Michael - Encino CA
Hedvat; Michael - Monrovia CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof Grant 11,377,477 - Bernett , et al. July 5, 2	2022-07-05
Bispecific And Monospecific Antibodies Using Novel Anti-pd-1 Sequences App 20220204624 - Bernett; Matthew ; et al.	2022-06-30
Bispecific Antibodies That Bind Pd-l1 And Cd28 App 20220135684 - Desjarlais; John R. ; et al.	2022-05-05
Bispecific and monospecific antibodies using novel anti-PD-1 sequences Grant 11,312,770 - Bernett , et al. April 26, 2	2022-04-26
Heterodimeric Antibodies That Bind Prostate Specific Membrane Antigen (psma) And Cd3 App 20220119525 - Desjarlais; John R. ; et al.	2022-04-21
Anti-cd28 Compositions App 20220119530 - Desjarlais; John R. ; et al.	2022-04-21
Heterodimeric Antibodies That Bind Msln And Cd3 App 20220106403 - Desjarlais; John R. ; et al.	2022-04-07
Anti-cd28 Compositions App 20220098306 - Desjarlais; John R. ; et al.	2022-03-31
Bispecific checkpoint inhibitor antibodies Grant 11,236,170 - Bernett , et al. February 1, 2	2022-02-01
Targeted Il-12 Heterodimeric Fc-fusion Proteins App 20210355185 - Bernett; Matthew ; et al.	2021-11-18
Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20210253706 - Bernett; Matthew J. ; et al.	2021-08-19
Pd-1 Targeted Il-15/il-15ralpha Fc Fusion Proteins With Improved Properties App 20210230243 - Desjarlais; John ; et al.	2021-07-29
Untargeted And Targeted Il-10 Fc-fusion Proteins App 20210171596 - Moore; Gregory ; et al.	2021-06-10
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant 10,981,992 - Bernett , et al. April 20, 2	2021-04-20
Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20210095030 - Bernett; Matthew ; et al.	2021-04-01
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant 10,793,632 - Bernett , et al. October 6, 2	2020-10-06
Bispecific checkpoint inhibitor antibodies Grant 10,787,518 - Bernett , et al. September 29, 2	2020-09-29
Pd-1 Targeted Il-15/il-15ralpha Fc Fusion Proteins And Uses In Combination Therapies Thereof App 20200140512 - Bernett; Matthew ; et al.	2020-05-07
Bispecific Checkpoint Inhibitor Antibodies App 20190389954 - Bernett; Matthew ; et al.	2019-12-26
Bispecific Checkpoint Inhibitor Antibodies App 20190382495 - Bernett; Matthew ; et al.	2019-12-19
Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20190270816 - Bernett; Matthew ; et al.	2019-09-05
Bispecific And Monospecific Antibodies Using Novel Anti-pd-1 Sequences App 20190263909 - Bernett; Matthew ; et al.	2019-08-29
Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20180127501 - Bernett; Matthew ; et al.	2018-05-10
Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis App 20070104714 - Agus; David B. ; et al.	2007-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.